JPH02250842A - Optically active compound - Google Patents

Optically active compound

Info

Publication number
JPH02250842A
JPH02250842A JP1072220A JP7222089A JPH02250842A JP H02250842 A JPH02250842 A JP H02250842A JP 1072220 A JP1072220 A JP 1072220A JP 7222089 A JP7222089 A JP 7222089A JP H02250842 A JPH02250842 A JP H02250842A
Authority
JP
Japan
Prior art keywords
compound
formula
optically active
ethyl ether
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1072220A
Other languages
Japanese (ja)
Other versions
JPH0825940B2 (en
Inventor
Seiichi Takano
誠一 高野
Kuniro Ogasawara
国郎 小笠原
Yoshiisa Sekiguchi
喜功 関口
Yoichi Shimazaki
洋一 島崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Soda Co Ltd
Original Assignee
Daiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiso Co Ltd filed Critical Daiso Co Ltd
Priority to JP1072220A priority Critical patent/JPH0825940B2/en
Publication of JPH02250842A publication Critical patent/JPH02250842A/en
Publication of JPH0825940B2 publication Critical patent/JPH0825940B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Epoxy Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NEW MATERIAL:An optically active compound of formula A (Bn is benzyl; *represents an asymmetric carbon). EXAMPLE:The optically active (R) compound of formula (A)-1. USE:An synthetic intermediate of milbemycin beta2 which occurs in nature and is effective against parasites in domestic animals. PREPARATION:The reaction of the compound of formula 1 with triethyl orthoacetate and pivalic acid gives the compound of formula 2 (Et is ethyl), the product is reduced with diisobutylaluminum hydride to form the compound of formula 3. The product is allowed to react with triphenylphosphine and carbon tetrachloride to give the compound of formula 4. Then, the compound is allowed to react with n-butyl lithium to give the compound of formula (A)-1, which is useful as an intermediate of milbemycin beta2 of formula I (Me is methyl), especially the compound of formula II, which is the upper half moiety of formula I, from the optically active (S) compound of formula 1.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、家畜の寄生虫病に効果があるとして知られて
いるミルベマイシン(mi lbemycin)β2製
造のための中間体である光学活性化合物に関する。ざら
に詳細には、下記式で表わされるミルベマイシンβ2の
北半球部分である下記式(B)で表わされる化合物を製
造するための中間体に関する。
Detailed Description of the Invention (Field of Industrial Application) The present invention relates to an optically active compound which is an intermediate for the production of milbemycin β2, which is known to be effective against parasitic diseases of livestock. . More specifically, the present invention relates to an intermediate for producing a compound represented by the following formula (B), which is the northern hemisphere portion of milbemycin β2 represented by the following formula.

ミルベマイシンβ2 (B) (従来の技術及び解決すべき課題) ミルベマイシンβ2は天然に存在する化合物として知ら
れているが、一般に上記の如き特異な性質をもつ天然産
の化合物は光学活性体であることが多い。これらは極め
て微量でその効果を発揮するが、天然から産出される量
も極めて微量であるため天然物からの抽出は非効率的で
あって実用性に乏しい。従ってこのものが合成によって
量産されることは非常に意義の深いことである。
Milbemycin β2 (B) (Prior art and problems to be solved) Milbemycin β2 is known as a naturally occurring compound, but generally, naturally occurring compounds with the above-mentioned unique properties are optically active compounds. There are many. These exert their effects in extremely small amounts, but since the amounts produced from nature are also extremely small, extraction from natural products is inefficient and impractical. Therefore, it is of great significance that this product can be mass-produced by synthesis.

(課題を解決するための手段) 本発明は、ミルベマイシンβ2を製造するための中間体
である下記式(A>で表わされる光学活性化合物を提供
するものである。
(Means for Solving the Problems) The present invention provides an optically active compound represented by the following formula (A>) which is an intermediate for producing milbemycin β2.

すなわち、本発明は、下記式(A> 本発明の光学活性化合物には(R)体及び(S)体の2
種類の光学異性体があり、このうちミルベマイシンβ2
製造のための中間体となるのは(R)体である。
That is, the present invention provides that the optically active compound of the present invention has the following formula (A>): (R) form and (S) form.
There are several types of optical isomers, among which milbemycin β2
The intermediate for production is the (R) form.

上記式(A>化合物のうち(R)体の合成法を以下の合
成経路工に従って説明する。但し、下記においてBnは
ベンジル基、Etはエチル基を表わす。
A method for synthesizing the (R) form of the above formula (A> compound) will be explained according to the following synthetic route. However, in the following, Bn represents a benzyl group and Et represents an ethyl group.

(上記式(A>において、Bnはベンジル基を表わし、
*の符号は不斉炭素原子を表わす)で表わされる光学活
性化合物である。
(In the above formula (A>, Bn represents a benzyl group,
The symbol * represents an asymmetric carbon atom).

体の化合物(A)−1が得られる。出発物質の化合物(
1)として光学活性(R)体のものを使用すれば、上記
同様にして目的物である(S)体の化合物(^)−2が
得られる。このものは他の有用な光学活性化合物の合成
原料として期待しうる。
Compound (A)-1 is obtained. Compound of starting material (
If the optically active (R) form is used as 1), the target compound (S) form of Compound (^)-2 can be obtained in the same manner as above. This product can be expected as a raw material for the synthesis of other useful optically active compounds.

(A>−1 上記出発物質である光学活性(S)体の化合物(1)は
既知の方法によって得られる(高野、関口、佐原、小笠
原: 5ynthesis 1987.139 )。
(A>-1) The optically active (S) form of Compound (1), which is the starting material, can be obtained by a known method (Takano, Sekiguchi, Sahara, Ogasawara: 5ynthesis 1987.139).

化合物(1)をトリエチルオルソアセテート及びピバリ
ン酸と反応させて化合物(2)とし、これをジイソブチ
ルアルミニウムヒドリドで還元して化合物(3)とする
。次に化合物(3)とトリフェニルホスフィン及び四臭
化炭素を反応させて化合物(4)とした侵、n−ブチル
リチウムと反応させることによって本発明の目的物であ
る(R)(A>−2 上記得られた(R)体の化合物(A)−1は、下記の合
成経路■に従って、ミルベマイシンβ2の北半球部分で
ある前記化合物(B)を製造するための原料となる化合
物(7)へ変換することができる。
Compound (1) is reacted with triethyl orthoacetate and pivalic acid to form compound (2), which is reduced with diisobutylaluminum hydride to form compound (3). Next, compound (3) was reacted with triphenylphosphine and carbon tetrabromide to form compound (4), which was then reacted with n-butyllithium (R) (A>- 2. Compound (A)-1 in the (R) form obtained above is converted into compound (7), which is a raw material for producing the compound (B), which is the northern hemisphere portion of milbemycin β2, according to the following synthetic route (1). can be converted.

(A>−1 とができる。上記光学活性エピクロロヒドリンとしては
、高光学純度のものとして本出願人に係る特開昭61−
132196@公報及び特開昭62−6697号公報、
又は特願昭63−284881号明細書記載の方法によ
って得られたものを用いることができる。
(A>-1).The above-mentioned optically active epichlorohydrin is one with high optical purity, which is disclosed in Japanese Patent Application Laid-open No. 61-11111, filed by the present applicant.
132196@publication and Japanese Patent Application Laid-open No. 62-6697,
Alternatively, those obtained by the method described in Japanese Patent Application No. 63-284881 can be used.

ミルベマイシンβ2の北半球部分である前記化合物(B
)を製造するための原料としては、上記化合物(7)の
他に、下記合成経路■に従って得られる化合物(17)
が用いられる。下記においてTMSはトリメチルシリル
基、Bnはベンジル基、phはフェニル基を表わす。
The compound (B
), in addition to the above compound (7), compound (17) obtained according to the following synthetic route
is used. In the following, TMS represents a trimethylsilyl group, Bn represents a benzyl group, and pH represents a phenyl group.

上記合成反応において、化合物(A)−1に(R)−(
−)−エピクロロヒドリンを反応させて化合物(5)を
合成し、これを塩基処理して化合物(6)となし、これ
にアセチレンガスを反応させて光学活性(4R,9R)
体の化合物(7)とするこTMS 上記出発物質である光学活性(R)体の化合物(8)は
既知の方法によって得られる(高野、関口、佐歴、小笠
原:5ynthesis 1987.139 )。
In the above synthesis reaction, compound (A)-1 is given (R)-(
-)-Epichlorohydrin is reacted to synthesize compound (5), which is treated with a base to form compound (6), which is reacted with acetylene gas to form optically active (4R, 9R)
Compound (7) and TMS The above-mentioned starting material, Compound (8) in the optically active (R) form, can be obtained by a known method (Takano, Sekiguchi, Sake, Ogasawara: 5ynthesis 1987.139).

上記化合物(8)を水酸化ナトリウム、水酸化カリウム
、水酸化リチウム等の水酸化アルカリ金属、又は水酸化
カルシウム、水酸化マグネシウム等の水酸化アルカリ土
類金属などの塩基の存在下で塩化プロパルギル、臭化プ
ロパルギル、ヨウ化プロパルギル等のハロゲン化プロパ
ルギルと反応させて化合物(9)を合成する。この化合
物(9)を0−ブチルリチウム、水素化リチウム、水素
化ナトリウム、グリニヤール試薬等の塩基の存在下で塩
化トリメチルシラン等のハロゲン化トリメチルシランと
反応させて化合物(10)に変換する。
The above compound (8) is treated with propargyl chloride in the presence of a base such as an alkali metal hydroxide such as sodium hydroxide, potassium hydroxide, or lithium hydroxide, or an alkaline earth metal hydroxide such as calcium hydroxide or magnesium hydroxide. Compound (9) is synthesized by reacting with a propargyl halide such as propargyl bromide or propargyl iodide. This compound (9) is converted to compound (10) by reacting with a halogenated trimethylsilane such as trimethylsilane chloride in the presence of a base such as 0-butyllithium, lithium hydride, sodium hydride, or a Grignard reagent.

化合物(10)をテトラヒドロフラン、エチルエーテル
、ジメトキシエタン等の溶媒中n−ブチルリチウム等の
塩基の存在下で転位させて化合物(11)とし、次いで
この化合物(11)をテトラヒドロフラン、エチルエー
テル、ジメトキシエタン、クロロホルム、塩化メチレン
、四塩化炭素等の溶媒中フッ化カリウム、フッ化水素、
フッ化テトラ−ローブチルアンモニウム等のフッ素試薬
を作用させてトリメチルシリル基(TMS)を除去し化
合物(12)とする。この化合物(12)の3位の水酸
基をエステル化して化合物(13)とし、これを塩基処
理して反転させ化合物(14)に変換する。これを酸化
白金(IV)の存在下で水素添加して化合物(15)に
し、さらに水酸化パラジウム(II>の存在下で水素化
分解すると化合物(16)となる。この化合物(16)
を白金黒存在下に酸処理すると光学活性(43,5R)
体の化合物(17)が得られる。
Compound (10) is rearranged to give compound (11) in the presence of a base such as n-butyllithium in a solvent such as tetrahydrofuran, ethyl ether, or dimethoxyethane, and then this compound (11) is rearranged in a solvent such as tetrahydrofuran, ethyl ether, or dimethoxyethane. , potassium fluoride, hydrogen fluoride, in a solvent such as chloroform, methylene chloride, carbon tetrachloride, etc.
The trimethylsilyl group (TMS) is removed by the action of a fluorine reagent such as tetralobylammonium fluoride to obtain compound (12). The hydroxyl group at the 3-position of this compound (12) is esterified to form a compound (13), which is then treated with a base to be inverted and converted to a compound (14). This is hydrogenated in the presence of platinum (IV) oxide to give compound (15), and further hydrogenolyzed in the presence of palladium hydroxide (II>) to give compound (16).This compound (16)
When treated with acid in the presence of platinum black, it becomes optically active (43,5R)
Compound (17) is obtained.

化合物(B)の合成は、前記化合物(7)と上記化合物
(17)を原料として下記の合成経路IVによって製造
することができる。下記においてBnはベンジル基、T
BDMSはt−ブチルジメチルシリル基を表わす。
Compound (B) can be synthesized by the following synthetic route IV using the above compound (7) and the above compound (17) as raw materials. In the following, Bn is a benzyl group, T
BDMS represents t-butyldimethylsilyl group.

(B) 上記反応において、化合物(7)にn−ブチルリチウム
を加えて反応させた後、化合物(17)を反応させ、水
酸基をシリルエーテルで保護して化合物(18)とする
。これを還元してシスオレフィンとした後選択的にエポ
キシ化し、さらに還元して開環させ化合物(19)とす
る。化合物(19)をフッ素試薬と反応させてシリル基
を除去すると、化合物(B)とそのエピマーが得られる
。このエピマーは酸化してスピロケトンとした後ヒドリ
ド還元することにより化合物(B)へ変換できる。この
化合物(B)は、ミルベマイシンβ2の光学活性な北半
球部分に相当し、ミルベマイシンβ2を製造するための
重要な中間体となる。
(B) In the above reaction, n-butyllithium is added to compound (7) and reacted, and then compound (17) is reacted, and the hydroxyl group is protected with silyl ether to form compound (18). This is reduced to give a cis-olefin, which is then selectively epoxidized, and further reduced to open the ring to give compound (19). When compound (19) is reacted with a fluorine reagent to remove the silyl group, compound (B) and its epimer are obtained. This epimer can be converted to compound (B) by oxidizing it to a spiroketone and then reducing it with hydride. This compound (B) corresponds to the optically active northern hemisphere portion of milbemycin β2 and is an important intermediate for producing milbemycin β2.

化合物(B)の合成原料である前記光学活性(4R,9
R)体の化合物(7)及び光学活性(4S。
The optically active (4R,9
Compound (7) in R) form and optical activity (4S.

5R)体の化合物(17)の代りに、それぞれの光学異
性体である(43.93)化合物(7′)及び(4R,
53)化合物(17Mを用いれば化合物(B)の光学異
性体である化合物(B′)が1qられる。、なお、上記
(43,93−)化合物(7′)は、前記合成経路■に
おいて、原料化合物(A)−1の代りに化合物(A)−
2を用い、また化合物(^)−1から化合物(5)への
反応に際して用いた(R)−(−)−エピクロロヒドリ
ンの代りに(S)−(+)−エビクロロヒドリンを用い
て上記同様に行って製造することができる。また(4R
,53)化合物(17Mは、前記合成経路■において、
原料の光学活性(R)体の化合物(8)の代りに(S)
体の化合物を用いて同様に行えば得ることができる。
Instead of Compound (17) of the 5R) form, the respective optical isomers of the Compound (43.93) (7') and (4R,
53) If compound (17M) is used, 1q of compound (B'), which is an optical isomer of compound (B), will be obtained. In addition, the above (43,93-) compound (7') is Compound (A)- instead of starting compound (A)-1
2, and (S)-(+)-epichlorohydrin was used instead of (R)-(-)-epichlorohydrin used in the reaction from compound (^)-1 to compound (5). It can be manufactured in the same manner as above. Also (4R
, 53) Compound (17M is the compound (17M) in the above synthetic route (■),
(S) in place of the optically active (R) compound (8) of the raw material
It can be obtained by performing the same procedure using a compound of the same type.

(実 施 例) 実施例1 〈化合物(2)の合成〉 目 化合物(1)  7,09a (36,9m mof>
にトリエチルオルソアセテート30. oa (185
m mol )及びピバリンl! 226mg (2,
21m mol )を加え、Dean−3tark装置
を付し、アルゴン気流中140℃で12時間加熱した。
(Example) Example 1 <Synthesis of compound (2)> Compound (1) 7,09a (36,9m mof>
Triethyl orthoacetate 30. oa (185
m mol ) and pivalin l! 226mg (2,
21 mmol) was added, a Dean-3 tark apparatus was attached, and the mixture was heated at 140° C. for 12 hours in an argon stream.

減圧下でトリエチルオルソアセテートを留去し、得られ
た残留物をシリカゲル250gを用いたカラムクロマト
グラフィーに付し、エチルエーテル:ヘキサン=1:2
0(容量)の流分から無色油状の化合物(2>  7.
120(収率73%)を得た。
Triethyl orthoacetate was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography using 250 g of silica gel to obtain ethyl ether:hexane=1:2.
A colorless oily compound (2>7.
120 (yield 73%) was obtained.

元素分析  CIBH2203 CH 理論値(%)    73.25  8.45分析値(
%)    73,03  8.511Rνmax  
(neat)  1730cm−11H−NMR(CD
α3) δ:1.07    (3H。
Elemental analysis CIBH2203 CH Theoretical value (%) 73.25 8.45 Analysis value (
%) 73,03 8.511Rνmax
(neat) 1730cm-11H-NMR (CD
α3) δ: 1.07 (3H.

1.24     (3H。1.24 (3H.

2803〜2.04(3H。2803-2.04 (3H.

3.97     (2H。3.97 (2H.

4.12     (2H。4.12 (2H.

4.49     (2N。4.49 (2N.

5.54〜5.72 (2H。5.54-5.72 (2H.

7、33     (51゜ MS m/e  :  155 (M”く化合物(3)
の合成〉 d、  J=6.6Hz > t、  J=7.1Hz ) m) d) a、  J−7,1Hz > S、 ) m) S) −OBn ) 、 91 (100%)上記得られた化
合物(2) 6.944g (26,30m mof 
)のトルエン200rd溶液中にジイソブチルアルミニ
ウムヒドリド3.741g (26,30m mol 
>をアルゴン気流中−90℃で加え、同温度で1時間撹
拌した。
7, 33 (51°MS m/e: 155 (M” compound (3)
Synthesis > d, J=6.6Hz > t, J=7.1Hz) m) d) a, J-7,1Hz > S, ) m) S) -OBn), 91 (100%) obtained above Compound (2) 6.944g (26,30m mof
) diisobutylaluminum hydride 3.741g (26.30m mol) in toluene 200rd solution
> was added at -90°C in an argon stream, and the mixture was stirred at the same temperature for 1 hour.

1規定塩酸を加えてエチルエーテルで抽出した後、エー
テル層を飽和重曹水、飽和食塩水で順次洗浄し、無水W
L酸マグネシウムで乾燥した。減圧下で溶媒を留去した
後、得られた残漬をシリカゲル200gを用いたカラム
クロマトグラフィーに付し、エチルエーテル:ヘキサン
=1:15(容量)の流分から原料化合物(2>  1
44mg(収率2%)を得、続いてエチルエーテル:ヘ
キサン=1:15→1:19(容量)の流分から無色油
状の化合物(3)5.0500 (収率88%)を得た
After adding 1N hydrochloric acid and extracting with ethyl ether, the ether layer was washed successively with saturated sodium bicarbonate solution and saturated saline solution, and anhydrous W.
Dry with magnesium chloride. After distilling off the solvent under reduced pressure, the obtained residue was subjected to column chromatography using 200 g of silica gel, and the raw material compound (2>1
44 mg (yield 2%) was obtained, and subsequently, 5.0500 mg (yield 88%) of compound (3) as a colorless oil was obtained from a flow of ethyl ether:hexane=1:15→1:19 (volume).

〔α) ! −20,43° (c= 1.008. 
CH(la3)元素分析  C141−1ta O2 理論値(%) 分析値(%) IR1,1maX  (neat) ’H−NMR(CDC13) δ:1.09    (3H。
[α)! -20,43° (c= 1.008.
CH(la3) elemental analysis C141-1ta O2 Theoretical value (%) Analytical value (%) IR1,1maX (neat) 'H-NMR (CDC13) δ: 1.09 (3H.

2.30〜2.50(2H。2.30-2.50 (2H.

2.81    (IH。2.81 (IH.

3.97    (2H。3.97 (2H.

CH 77,02B、32 76.62  8.51 1725Cm−1 4.49    (2H,s) 5.50〜5.74 (2H,m) 7.33     (5tl、  S)9、γ3   
  (1M、  t、  J=2.2tfz )MS 
m/e  :  218 (M” ) 、 91 (1
00%)C14H+s O2理論値218.1307分
析値218.1287 〈化合物(4)の合成〉 トリフェニルホスフィン24.03g(92,68mm
ol)の塩化メチレン90rIdl溶液に四臭化炭素1
5.37!11(46,34m mol >をアルゴン
気流中氷冷下で加え、同温度で15分間撹拌した。これ
に上記得られた化合物(3)  5.05g(23,1
7mmol)の塩化メチレンioml溶液を同温度で加
え1時間撹拌した。塩化メチレン200m1で稀釈した
侵、飽和重曹水、飽和食塩水で順次洗浄し無水硫酸マグ
ネシウムで乾燥した。減圧下で溶媒を留去後、得られた
残漬44゜94(1をエチルエーテル300dに溶かし
グラスフィルターで濾過した。濾液について減圧下で溶
媒を留去後、得られた残渣13.18(lをシリカゲル
400(lを用いたカラムクロマトグラフィーに付し、
エチルエーテル:ヘキサン=1:15(容量)の流分か
ら化合物(4>  7.67g(収率89%)を得た。
CH 77,02B, 32 76.62 8.51 1725Cm-1 4.49 (2H, s) 5.50-5.74 (2H, m) 7.33 (5tl, S) 9, γ3
(1M, t, J=2.2tfz) MS
m/e: 218 (M”), 91 (1
00%) C14H+s O2 theoretical value 218.1307 analytical value 218.1287 <Synthesis of compound (4)> Triphenylphosphine 24.03 g (92.68 mm
1 carbon tetrabromide to 90 rIdl methylene chloride solution of
5.37!11 (46.34 mmol) was added under ice-cooling in an argon stream and stirred at the same temperature for 15 minutes.To this was added 5.05 g (23.1 mmol) of the compound (3) obtained above.
A solution of 7 mmol) of methylene chloride in ioml was added at the same temperature and stirred for 1 hour. The mixture was washed successively with diluted diluted with 200 ml of methylene chloride, saturated aqueous sodium bicarbonate, and saturated brine, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure, the resulting residue 44.94 (1) was dissolved in 300 d of ethyl ether and filtered through a glass filter. After distilling off the solvent under reduced pressure on the filtrate, the obtained residue 13.18 ( 1 was subjected to column chromatography using silica gel 400 (1),
Compound (4>7.67 g (yield: 89%) was obtained from a stream of ethyl ether:hexane=1:15 (volume).

〔α〕萱−6.61° (c= 1.048. CHC
l3)IRvmax  (neat)  1615cm
−1’H−NMR(CHCl13) δ:1.05    (3H,d、  J=6.4Hz
 )1.95〜2.60 (3H,m) 3.99    (2N、  m) 4.51    (2H,S) 5.51〜5.69 <2tl、  m)6.38  
  (1H,t、  J=7.1Hz )7.33  
  (5H,S) MS m/e :  374 (M” ) 、 91 
(100%)〈化合物(A)−1の合成〉 (A)−1 上記得られた化合物(4) γ、61g (20,3m
 mof)のテトラヒドロフラン150d溶液中にn−
ブチルリチウム(10%W/V n−ヘキサン溶液>2
7.5m(46,8m mol>をアルゴン気流中−7
8℃で加え、同温度で30分間撹拌した。水50dを加
えてエチルエーテルで抽出し飽和食塩水で洗浄後、無水
硫酸マグネシウムで乾燥した。減圧下で溶媒を留去後、
シリカゲル2001Jを用いたカラムクロマトグラフィ
ーに付し、エチルエーテル:ヘキサン=1:50(容量
)の流分から無色油状の化合物(A)−13,59g(
収率82%)を得た。
[α] 萱-6.61° (c= 1.048.CHC
l3) IRvmax (neat) 1615cm
-1'H-NMR (CHCl13) δ: 1.05 (3H, d, J=6.4Hz
) 1.95~2.60 (3H, m) 3.99 (2N, m) 4.51 (2H, S) 5.51~5.69 <2tl, m) 6.38
(1H, t, J=7.1Hz)7.33
(5H, S) MS m/e: 374 (M”), 91
(100%) <Synthesis of compound (A)-1> (A)-1 Compound (4) obtained above γ, 61 g (20.3 m
mof) in a 150d solution of n- in tetrahydrofuran.
Butyl lithium (10% W/V n-hexane solution>2
7.5 m (46,8 m mol>) in an argon stream -7
The mixture was added at 8°C and stirred at the same temperature for 30 minutes. 50 d of water was added, extracted with ethyl ether, washed with saturated brine, and dried over anhydrous magnesium sulfate. After distilling off the solvent under reduced pressure,
Column chromatography using silica gel 2001J was carried out to obtain 13.59 g of colorless oily compound (A) (
A yield of 82%) was obtained.

〔α〕菅−6.40”  (C= 1.000. CH
α3)元素分析  C+s Hsa O2 Cト1 理論値(%)    84.07  8.47分析値(
%)    84,34  8.47IR17max 
 (neat)  2140.3210cm−11H−
NMR(CDα3) δ:1.12    3H,d、  J=6.6Hz 
>1.98    1H,t、  J=2.4Hz )
2.09〜2.28 2H,m) 2.36    1H,m) 4.00    2H,m) 4.51    2H,S) 5.58〜5.78 2H,m> 7.33    5)1.S) MS m/e  :  214  M” ) 、 91
 (100%)このようにして得られた本発明の目的物
の一つである光学活性(R>体の化合物(A)−1は、
弓き続いて下記例で示すように化合物(5)、さらには
化合物(6)を経て、ミルベマイシンβ2の北半球部分
である化合物(B)を製造するための原料となる化合物
(7)へ変換できる。以下その合成例を示した。
[α] Suga-6.40" (C= 1.000. CH
α3) Elemental analysis C+s Hsa O2 Cto1 Theoretical value (%) 84.07 8.47 Analysis value (
%) 84,34 8.47IR17max
(neat) 2140.3210cm-11H-
NMR (CDα3) δ: 1.12 3H, d, J=6.6Hz
>1.98 1H,t, J=2.4Hz)
2.09-2.28 2H,m) 2.36 1H,m) 4.00 2H,m) 4.51 2H,S) 5.58-5.78 2H,m> 7.33 5)1. S) MS m/e: 214 M”), 91
(100%) The optically active (R> compound (A)-1, which is one of the objects of the present invention obtained in this way,
Subsequently, as shown in the example below, it can be converted to compound (7), which is the raw material for producing compound (B), which is the northern hemisphere portion of milbemycin β2, through compound (5) and then compound (6). . An example of its synthesis is shown below.

〈化合物(5)の合成〉 二塩化ジルコノセン1,86a (6,36m mol
)の塩化メチレン懸濁液にトリメチルアルミニウム2.
86g(39,7mmol)をアルゴン気流中室温で加
えて15分間撹拌した後、同温度で上記1ワられた化合
物(^) −11,70a (7,94m mol)の
塩化メチレン5d溶液を加えて13時間撹拌した。減圧
下で溶媒とトリメチルアルミニウムを留去(15mmH
o室温及び0.5mm1l(II 50℃で4時間)後
、残留物をn−ヘキサン(15dX 3回)で抽出しカ
ニユーレを用いて別の容器に移した。この容器にn−ブ
チルリチウム(1,65モルのn−ヘキサン溶液>7.
22me(11,91m mol>をアルゴン気流中−
78℃で加え、ざらに−30℃で30分間撹拌した。、
この温度で(R>−(−)−エピクロロヒドリン3.6
7g (39,7mnot)を加え、−20℃で12時
間撹拌した。飽和塩化アンモニウム水40rIJlを加
えた後エチルエーテルで抽出し、飽和重曹水、飽和食塩
水で順次洗浄後無水硫酸マグネシウムで乾燥した。減圧
下で溶媒を留去し、得られた残留物をシリカゲル100
gを用いたカラムクロマトグラフィーに付し、エチルエ
ーテル:ヘキサン=1:9(容量)の流分から化合物(
,5)  1.750(収率68%)を得た。
<Synthesis of compound (5)> Zirconocene dichloride 1,86a (6,36m mol
) in a methylene chloride suspension of trimethylaluminum 2.
After adding 86 g (39.7 mmol) at room temperature in an argon stream and stirring for 15 minutes, a 5d methylene chloride solution of the compound (^)-11,70a (7.94 mmol) prepared above was added at the same temperature. Stirred for 13 hours. The solvent and trimethylaluminum were distilled off under reduced pressure (15 mmH
After room temperature and 0.5 mm 1 l (II 4 hours at 50° C.), the residue was extracted with n-hexane (15 dX 3 times) and transferred to another container using a cannula. In this container, n-butyl lithium (1.65 mol n-hexane solution>7.
22me (11,91m mol>) in an argon stream -
The mixture was added at 78°C and roughly stirred at -30°C for 30 minutes. ,
At this temperature (R>-(-)-epichlorohydrin 3.6
7g (39.7mnot) was added and stirred at -20°C for 12 hours. After adding 40 rIJl of saturated ammonium chloride water, the mixture was extracted with ethyl ether, washed successively with saturated sodium bicarbonate water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified using silica gel 100.
The compound (
, 5) 1.750 (yield 68%) was obtained.

〔α〕萱+9.80° (c= 1.016. CHα
3)元素分析  C鵞9H2702α CH(j! 70.68  8.43 10.9B 70.67  8.51 10.89 1665、3450cnr1 理論値(%) 分析値(%) IRl/maX  (neat) ’H−NMR(CDC13) δ:0.96    (3H。
[α] 萱+9.80° (c= 1.016. CHα
3) Elemental analysis C-9H2702α CH (j! 70.68 8.43 10.9B 70.67 8.51 10.89 1665, 3450cnr1 Theoretical value (%) Analytical value (%) IRl/maX (neat) 'H -NMR (CDC13) δ: 0.96 (3H.

1.61    (31゜ 2.00    (2H。1.61 (31゜ 2.00 (2H.

2.28    (2H。2.28 (2H.

2.41    (IH。2.41 (IH.

d、  J=6.3Hz ) ・brs ) d、  J=6.8H2) t、  J=7.3H2) d、  J=4.9H2゜ exchangeable with 020 )2.
10〜2.52 (IH,m) 3.28〜3.88(3H,m) 3.96     (2N、m) 4.49    (2H,S) 5.13     (1)1.  t、  J=7.3
H2)5.43〜5.68 (2tl、  m)7.3
3     (5tl、  s)く化合物(6)の合成
〉 上記得られた化合物(5)  438mg(1,36m
 mol>のテトラヒドロフラン5d溶液に粉末水酸化
ナトリウム163ma (4,07m mol )をア
ルゴン気流中室温で加えて同温度で9時間撹拌した。エ
チルエーテル60dで稀釈後、飽和食塩水で3回洗浄し
無水硫酸マグネシウムで乾燥した。減圧下で溶媒留去後
、得られた残留物をシリカゲル159を用いたカラムク
ロマトグラフィーに付し、エチルエーテル:ヘキサン=
1:9(容量)の流分から無色油状の化合物(6)  
362mg(収率93%)を得た。
d, J=6.3Hz) ・brs) d, J=6.8H2) t, J=7.3H2) d, J=4.9H2゜exchangeable with 020)2.
10-2.52 (IH, m) 3.28-3.88 (3H, m) 3.96 (2N, m) 4.49 (2H, S) 5.13 (1)1. t, J=7.3
H2) 5.43-5.68 (2tl, m) 7.3
3 (5tl, s) Synthesis of compound (6)> Compound (5) obtained above 438mg (1,36m
163 ma (4.07 mmol) of powdered sodium hydroxide was added to a solution of 5d of tetrahydrofuran in an argon stream at room temperature, and the mixture was stirred at the same temperature for 9 hours. After diluting with 60 d of ethyl ether, the mixture was washed three times with saturated brine and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, the obtained residue was subjected to column chromatography using silica gel 159, and ethyl ether:hexane=
Compound (6) as a colorless oil from a 1:9 (volume) stream
362 mg (yield 93%) was obtained.

〔α〕萱−3,35° (C= 1.014. CDC
f3)元素分析  Cl9H2BO2 理論値(%) 分析値(%) IRνmax  (neat) ’H−NMR(CDCf3) δ:0.95    (2H。
[α] 萱-3,35° (C= 1.014. CDC
f3) Elemental analysis Cl9H2BO2 Theoretical value (%) Analytical value (%) IRνmax (neat) 'H-NMR (CDCf3) δ: 0.95 (2H.

1.59    (3H。1.59 (3H.

1684〜2.11 (2H。1684-2.11 (2H.

2.13〜2.40 (2H。2.13-2.40 (2H.

2.47    (IH。2.47 (IH.

2、70    (il+。2, 70 (il+.

2.90    (IH。2.90 (IH.

3.96    (2H。3.96 (2H.

4.4&    (2tl。4.4 & (2tl.

5.15    (IH。5.15 (IH.

H 79,689゜15 79.61  9.10 1670cnr1 d、  J=6.4Hz ) S) m) m) dd。H 79,689゜15 79.61 9.10 1670cnr1 d, J=6.4Hz) S) m) m) dd.

t。t.

m) d、  J=4.9H2) S) t、  J−7,1Hz ) J=2.7Hz 、 5.1Hz ) J=4.9Hz ) 5.413〜5.67 (2H,m> 7.32     (58,3) MS  m/e  :  285 (M十 −1>、9
1  (100%)C19H2502理論@ 285.
1855  (M”−1>分析値285゜1894  
(M” −1)く化合物(7)の合成〉 ジメチルスルホキシド3(7!に水素化ナトリウム(6
0%油中>  789m0 (19,7m mol>を
アルゴン気流中室温で加え、水素の発生が停止するまで
(約50分間)70℃に加熱した。1qられた緑透明溶
液を室温に戻した後、濃硫酸及びシリカゲル洗気ビンを
通したアセチレンガスを40分間導入した。これに上記
)qられた化合物(6)  i、41g (4,93m
 mol)のジメチルスルホキシド10d溶液を室温で
加え4.5時間撹拌した。水冷下で反応液に水50m1
を滴下しエチルエーテルで抽出した。エーテル層を飽和
重曹水、飽和食塩水で順次洗浄し、無水硫酸マグネシウ
ムで乾燥後、減圧下で溶媒を留去した。
m) d, J=4.9H2) S) t, J-7,1Hz) J=2.7Hz, 5.1Hz) J=4.9Hz) 5.413-5.67 (2H, m>7. 32 (58,3) MS m/e: 285 (M-1>, 9
1 (100%) C19H2502 theory @ 285.
1855 (M”-1>Analysis value 285°1894
(M”-1) Synthesis of compound (7)> Dimethyl sulfoxide 3 (7!) and sodium hydride (6
789 mO (19,7 mm mol) in 0% oil was added at room temperature under a stream of argon and heated to 70 °C until hydrogen evolution stopped (about 50 min). After returning 1 q of green clear solution to room temperature. , concentrated sulfuric acid and acetylene gas passed through a silica gel washing bottle were introduced for 40 minutes.To this was added compound (6) i, 41 g (4,93 m
A solution of 10 mol of dimethyl sulfoxide was added at room temperature and stirred for 4.5 hours. Add 50ml of water to the reaction solution under water cooling.
was added dropwise and extracted with ethyl ether. The ether layer was washed successively with saturated aqueous sodium bicarbonate and saturated brine, dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure.

得られた残留物をシリカゲル70(IIを用いたカラム
クロマトグラフィーに付し、エチルエーテル:ヘキサン
=1:4(容量)の流分から淡黄色油状の化合物(7)
  1.23g(収率80%)を得た。
The obtained residue was subjected to column chromatography using silica gel 70 (II), and from the flow of ethyl ether:hexane = 1:4 (volume), pale yellow oily compound (7) was obtained.
1.23 g (yield 80%) was obtained.

bp  196°C(0,5mm1g 、  Kuge
lrohr)(α)萱+7.55° (C= 1.03
2. CHα3)元素分析  C2182802 Cト1 理論値(%)    80.73  9.03分析値(
%)    80.70  9.22IRνmax  
(neat)  1670.3310.3460cm−
1’H−NMR(CDC13) δ:0.97    (3H,d、  J=6.6H2
)1.81    (3N、brs) 1.77〜2.10 (3H,m) 2.17    (IH,d、  J=5.1tlz。
bp 196°C (0.5mm1g, Kuge
lrohr) (α) 萱+7.55° (C= 1.03
2. CHα3) Elemental analysis C2182802 C-1 Theoretical value (%) 80.73 9.03 Analysis value (
%) 80.70 9.22IRνmax
(neat) 1670.3310.3460cm-
1'H-NMR (CDC13) δ: 0.97 (3H, d, J=6.6H2
) 1.81 (3N, brs) 1.77-2.10 (3H, m) 2.17 (IH, d, J=5.1tlz.

exchangeable with C20)2.2
3〜2.50 (5H,m) 3.75    1H,m) 3.95    2H,m) 4.50    2tl、  s) 5.15    1H,t、  J=7.1H2)5.
46〜5.65 2N、  m) 7.33     (51−1,s> MS m/e : 313 (M” +1> 、 91
 (100%)C21H2802理論値313.216
7  (M” +1>分析値313.2182  (M
++1>上記得られた光学活性(4R,9R)体の化合
物(7)は、前記したようにミルベマイシンβ2の北半
球部分である化合物(B)を製造する原料に利用される
exchangeable with C20)2.2
3-2.50 (5H, m) 3.75 1H, m) 3.95 2H, m) 4.50 2tl, s) 5.15 1H, t, J=7.1H2)5.
46~5.65 2N, m) 7.33 (51-1, s> MS m/e: 313 (M"+1>, 91
(100%) C21H2802 theoretical value 313.216
7 (M” +1>Analysis value 313.2182 (M
++1> The optically active (4R,9R) compound (7) obtained above is used as a raw material for producing compound (B), which is the northern hemisphere portion of milbemycin β2, as described above.

次に、上記化合物(B)を製造するための他方の原料化
合物(17)は、以下の例のようにして合成した。
Next, the other raw material compound (17) for producing the above compound (B) was synthesized as in the following example.

〈化合物(9)の合成〉 光学純度的100%eeの化合物(8)  1.00g
(5,21m mol) 、硫酸水素n−ブチルアンモ
ニウム88mg (0,26m mol )及び60%
(W/V)水酸化ナトリウム水溶液20m1の混合物中
に水冷下でプロパルギルブロマイド3.10a (26
,0m mof>を加え、アルゴン気流中室温で26時
間撹拌した。これに水及びエチルエーテルを加え、エー
テル層を分取して飽和食塩水で洗浄後、無水硫酸マグネ
シウムで乾燥した。溶媒を減圧下で留去し、1qられた
残留物をシリカゲル50gを用いたカラムクロマトグラ
フィーに付し、エチルエーテル:ヘキサン=1:50(
容量)の流分から無色油状の化合物(9)0.917g
(収率77%)を得た。
<Synthesis of compound (9)> Compound (8) with optical purity of 100% ee 1.00 g
(5,21 mmol), n-butylammonium hydrogen sulfate 88 mg (0,26 mmol) and 60%
(W/V) Propargyl bromide 3.10a (26
,0 m mof> was added, and the mixture was stirred at room temperature in an argon stream for 26 hours. Water and ethyl ether were added to this, and the ether layer was separated, washed with saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and 1q of the residue was subjected to column chromatography using 50 g of silica gel, and ethyl ether:hexane = 1:50 (
0.917 g of colorless oily compound (9) from the stream of
(yield 77%).

bp  130’C(0,2mmt1g、  Kuc+
elrohr)〔α〕″V −85,38”  (c=
 1.040. CHCl3)元素分析  C+s H
t802 H 理論値(%)    78.23  7.88分析値(
%)    77.58  7.90IRvmax  
(neat)  2110cm−1’H−NMR(CD
(1!3 ) δ:1.73    (3tl、 dd、  J=1.
7Hz 。
bp 130'C (0.2mmt1g, Kuc+
elrohr) [α]″V −85,38″ (c=
1.040. CHCl3) Elemental analysis C+s H
t802 H Theoretical value (%) 78.23 7.88 Analysis value (
%) 77.58 7.90IRvmax
(neat) 2110cm-1'H-NMR (CD
(1!3) δ:1.73 (3tl, dd, J=1.
7Hz.

2.40    (IN、  t、  J=2.5Hz
 )3.45〜3.60(2N、  III)4.19
    (21,t、  J=2.5)1z )4.5
0〜4.88 (ltl、  m)4.60    (
2H,s) 5.12〜6.02 (2N、  m)7.33   
 (5+1.  S) MS m/e :  189 (M” −CH=CH−
CH3) 。
2.40 (IN, t, J=2.5Hz
) 3.45-3.60 (2N, III) 4.19
(21,t, J=2.5)1z)4.5
0-4.88 (ltl, m) 4.60 (
2H, s) 5.12~6.02 (2N, m) 7.33
(5+1.S) MS m/e: 189 (M" -CH=CH-
CH3).

91 (100%) 6.8Hz 〈化合物(10)の合成〉 上記得られた化合物(9) 10. OOg(43,4
8m mof >のテトラヒビ0フ92150 エチルマグネシウムブロマイド−テトラヒドロフラン溶
液83.’61rd(108. 7m mof )をア
ルゴン気流中氷冷下で加え、同温度で3時間撹拌した後
、トリメチルシリルクロライド14.17a (130
.4m mol)を加えた。次いで飽和塩化アンモニウ
ム水50−を加えてエチルエーテルで抽出し、エーテル
層を飽和重曹水、飽和食塩水で順次洗浄後、無水硫酸マ
グネシウムで乾燥した。溶媒を減圧下で留去し、得られ
た残留物をシリカゲル250gを用いたカラムクロマト
グラフィーに付し、エチルエーテル:ヘキサン=1:3
0(容量)の流分から無色油状の化合物( 10 ) 
12.23a (収率93%)を得た。
91 (100%) 6.8Hz <Synthesis of compound (10)> Compound (9) obtained above 10. OOg(43,4
8m mof>tetrahydrofuran solution 92150 Ethylmagnesium bromide-tetrahydrofuran solution 83. '61rd (108.7 mmof) was added under ice-cooling in an argon stream, and after stirring at the same temperature for 3 hours, trimethylsilyl chloride 14.17a (130
.. 4 mmol) was added. Next, 50% of saturated aqueous ammonium chloride was added and extracted with ethyl ether, and the ether layer was washed successively with saturated aqueous sodium bicarbonate and saturated brine, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography using 250 g of silica gel, and ethyl ether:hexane=1:3
Compound (10) as a colorless oil from a stream of 0 (by volume)
12.23a (yield 93%) was obtained.

bp  130℃ (O12mmHg,  にuge 
l rohr )〔α)V−80.74° (c= 1
.018, CI(43元素分析  Cl8H2BO2
 S i    H 71、47   8.66 71、44   8.72 2180cm−1 理論値(%) 分析値(%) IR  νmaX  (neat) 1)−1−NMR (CDα3) δ:0.18    (9H。
bp 130℃ (O12mmHg,
l rohr ) [α) V-80.74° (c= 1
.. 018, CI (43 elemental analysis Cl8H2BO2
S i H 71,47 8.66 71,44 8.72 2180 cm-1 Theoretical value (%) Analytical value (%) IR νmaX (neat) 1)-1-NMR (CDα3) δ: 0.18 (9H.

1、71(31。1, 71 (31.

3、55〜3.73(2H。3, 55-3.73 (2H.

4、18    (2H。4, 18 (2H.

4、49〜4.79(IH。4, 49-4.79 (IH.

4、60    (2H。4, 60 (2H.

5、12〜6.01 (2H。5, 12-6.01 (2H.

7、34    (5H。7, 34 (5H.

MS m/e : 302 (M” C1BH2BO2 S 1 brs ) dd,  J=1.4Hz 、 7.1Hz )m) d,  J=2.9H2 ) m) S) m) S) )、91(100%) 理論値302.1703  (M” )分析値302.
1711  (M” )〈化合物(11)の合成〉 ト1 MS 上記得られた化合物(1 0)  16.0g( 53
m mol>のテトラヒドロフラン200−溶液に10
%(W/V)n−ブチルリチウム49. 7rd( 7
9m mol )をアルゴン気流中−80℃で加え4時
間同温度で撹拌した。飽和塩化アンモニウム水50dを
加えてエチルエーテルで抽出し、エーテル層を飽和重曹
水、飽和食塩水で順次洗浄後、無水硫酸マグネシウムで
乾燥した。溶媒を減圧下で留去し、得られた残留物をシ
リカゲル450gを用いたカラムクロマトグラフィーに
付し、エチルエーテル:ヘキサン=1ニア(容量)の流
分から無色油状の化合物(11)i4.5。
MS m/e: 302 (M" C1BH2BO2 S 1 brs) dd, J=1.4Hz, 7.1Hz) m) d, J=2.9H2) m) S) m) S) ), 91 (100% ) Theoretical value 302.1703 (M”) Analytical value 302.
1711 (M”) <Synthesis of compound (11)> 1 MS 16.0 g of compound (10) obtained above (53
10 m mol> of tetrahydrofuran 200-solution
% (W/V) n-butyllithium 49. 7rd ( 7
9 mmol) was added at -80°C in an argon stream, and the mixture was stirred at the same temperature for 4 hours. After adding 50 d of saturated ammonium chloride water and extracting with ethyl ether, the ether layer was washed successively with saturated sodium bicarbonate water and saturated brine, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography using 450 g of silica gel, and a colorless oily compound (11) i4.5 was extracted from a stream of ethyl ether:hexane=1 (volume). .

(収率90%)を得た。(yield 90%).

〔α〕萱+18.91”  (C= 0.624, C
HCe.3)元素分析  Cl8H2BO2S 1 CH 71,478,66 71,298,73 2170、3400cm−1 理論値(%) 分析値(%) IRνmaX  (neat) ’H−NMR(CD(J3 ) δ:0.17    (9N、  brs)1.12 
   (3tf、  d、  J=6.8112 )1
.86    (IH,d、  J=7.4H2゜ex
changeable with  D20 )2.2
8〜2.67 (IH,m) 3.94〜4.08(211,m) 4.24    (1)1. dd、  J=6.8H
2、7,4112’)4.52    (2N、  S
) 5.61〜5.82 (21′1.  m)7.33 
   (5H,S) MS m/e :  301 (M”−1> 、 91
 (100%)〈化合物(12)の合成〉 ト1 上記得られた化合物(11)  1.77g(5,86
mmol)のテトラヒドロフラン20rnl溶液に濃度
1.0molのフッ化テトラ−n−ブチルアンモニウム
−テトラヒドロフラン溶液17.6rnll (17,
6m mol>を至温で加え、アルゴン気流中同温度で
8分間撹拌した。減圧下で溶媒を留去し、得られた残留
物をシリカゲル30i)を用いたカラムクロマトグラフ
ィーに付し、エチルエーテル:ヘキサン−1ニア(容量
)の流分から無色油状の化合物(12)1.29Q (
収率96%)を得た。
[α] 萱+18.91” (C= 0.624, C
HCe. 3) Elemental analysis Cl8H2BO2S 1 CH 71,478,66 71,298,73 2170, 3400 cm-1 Theoretical value (%) Analytical value (%) IRνmaX (neat) 'H-NMR (CD (J3) δ: 0.17 (9N, brs) 1.12
(3tf, d, J=6.8112)1
.. 86 (IH, d, J=7.4H2゜ex
changeable with D20)2.2
8-2.67 (IH, m) 3.94-4.08 (211, m) 4.24 (1)1. dd, J=6.8H
2,7,4112')4.52 (2N, S
) 5.61~5.82 (21'1. m) 7.33
(5H, S) MS m/e: 301 (M"-1>, 91
(100%) <Synthesis of compound (12)> 1. Compound (11) obtained above 1.77 g (5,86
17.6 rnll of tetra-n-butylammonium fluoride-tetrahydrofuran solution with a concentration of 1.0 mol) in 20 rnl of tetrahydrofuran (17,
6 mmol> was added at the very temperature, and the mixture was stirred for 8 minutes at the same temperature in an argon stream. The solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography using silica gel 30i), and a colorless oily compound (12) 1. 29Q (
A yield of 96% was obtained.

bp  125℃ (0,2mmHg、  Kugel
rohr)〔α〕萱+18.15° (C= 1.14
6. CtlCb >IRνmax  (neat) 
 2100.3500cm−1’H−NMR(CD(1
’3  ) δ:1.12    (3H,d、  J=7.1)1
2 )t、82〜2.10  (ltf、   brs
、  exchangeablewith 020 ) 2.30〜2.70 (IH,m) 4.26    (IH,dd、  J=2.3H2、
5,1H2)4.51     (2H,S) 5.88〜5.82 (2H,m> 7.30     (511,S) MS m/e :  230 (M” ) 、 91 
(100%)C1s Hto 02  理論値230.
1307  (M+)分析値230.1293  (M
” )〈化合物(13)の合成〉 上記得られた化合物(12> 49.3mg(0,21
4mm01)のテトラヒドロフラン2d溶液に安息香酸
34.0mg(0,278m mol) 、トリフェニ
ルホスフィン84、0mg(0,321m not )
及びアゾジカルボン酸ジイソプロピル64.9mg(0
,321m mol )を順次アルゴン気流中水冷下で
加え、同温度で35分間撹拌した。
bp 125℃ (0.2mmHg, Kugel
rohr) [α] 萱+18.15° (C= 1.14
6. CtlCb > IRνmax (neat)
2100.3500cm-1'H-NMR (CD(1
'3) δ:1.12 (3H, d, J=7.1)1
2) t, 82~2.10 (ltf, brs
, exchangeable with 020) 2.30~2.70 (IH, m) 4.26 (IH, dd, J=2.3H2,
5,1H2) 4.51 (2H,S) 5.88~5.82 (2H,m> 7.30 (511,S) MS m/e: 230 (M”), 91
(100%) C1s Hto 02 Theoretical value 230.
1307 (M+) Analysis value 230.1293 (M
) <Synthesis of compound (13)> The compound obtained above (12> 49.3 mg (0,21
Benzoic acid 34.0 mg (0,278 mmol), triphenylphosphine 84.0 mg (0,321 m not ) in a tetrahydrofuran 2d solution of 4 mm01)
and diisopropyl azodicarboxylate 64.9 mg (0
, 321 mmol) were sequentially added under water cooling in an argon stream, and the mixture was stirred at the same temperature for 35 minutes.

減圧下で溶媒を留去し、得られた残留物をシリカゲル1
50を用いたカラムクロマトグラフィーに付し、エチル
エーテル:ヘキサン=1:15(容量)の流分から無色
油状の化合物(13) 53.4mg(収率75%)を
得た。
The solvent was distilled off under reduced pressure, and the resulting residue was purified using silica gel 1.
53.4 mg (yield 75%) of compound (13) as a colorless oil was obtained from a flow of ethyl ether:hexane=1:15 (volume).

bp  1N2℃ (0,04mmh、  にugel
rohr)〔α)9−31.74°  (C=  t、
008.  C3(1’ 3 )元素分析  C22H
2203 Cl−1 79,016□63 79.21  6.73 1720、2130.3290cm−1理論値(%) 分析値(%) IRljmaX  (neat) 1H−NMR(CDα3) δ:1.25    (3N、  d、  J=6.8
NZ >2.49    (IH,d、  J=2.2
H1’)2.78    (111,m> 4.00     (2H,III) 4.47    (20,S) 5.54    (IH,dd、  J=2.2H2、
6,IH2)5.68〜5.84 (2N、  m>7
.30     (5H,S) 7.38〜7.70(3H,m) 7.95〜8.16(2H,m) MS  m/e  :  334 (M十 )、91 
 (100%)C221−12203理論値334.1
568  (M” )分析値334.1535  (M
+ )〈化合物(14)の合成〉 上記得られた化合物(13) 2.776g(8,31
1mmof)のメタノール20rf11溶液に炭酸カリ
ウム1、723g (12,47m mol )を加え
、アルゴン気流中空温で1時間撹拌した。減圧下で溶媒
を留去し、エチルエーテル及び水を加えて振とうさせ、
エーテル層を分取した。次いで飽和食塩水で洗浄し、無
水硫酸マグネシウムで乾燥した後、減圧下で溶媒を留去
し、得られた残留物をシリカゲル80gを用いたカラム
クロマトグラフィーに付し、エチルエーテル:ヘキサン
=1:4(容量)の流分から無色油状の化合物(14)
 1.858g(収率97%)を得た。
bp 1N2℃ (0.04mmh,
rohr) [α)9-31.74° (C=t,
008. C3 (1' 3 ) elemental analysis C22H
2203 Cl-1 79,016□63 79.21 6.73 1720, 2130.3290 cm-1 Theoretical value (%) Analytical value (%) IRljmaX (neat) 1H-NMR (CDα3) δ: 1.25 (3N, d, J=6.8
NZ >2.49 (IH, d, J=2.2
H1') 2.78 (111, m> 4.00 (2H, III) 4.47 (20, S) 5.54 (IH, dd, J=2.2H2,
6, IH2) 5.68~5.84 (2N, m>7
.. 30 (5H, S) 7.38-7.70 (3H, m) 7.95-8.16 (2H, m) MS m/e: 334 (M10), 91
(100%) C221-12203 theoretical value 334.1
568 (M”) Analysis value 334.1535 (M
+ ) <Synthesis of compound (14)> Compound (13) obtained above 2.776 g (8,31
1.723 g (12.47 mmol) of potassium carbonate was added to a methanol 20rf11 solution of 1 mmof), and the mixture was stirred for 1 hour at temperature in an argon stream. The solvent was distilled off under reduced pressure, ethyl ether and water were added, and the mixture was shaken.
The ether layer was separated. After washing with saturated brine and drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography using 80 g of silica gel. Ethyl ether:hexane=1: Compound (14) as a colorless oil from a stream of 4 (by volume)
1.858 g (yield 97%) was obtained.

bp  162℃ (0,3mmHg、  にugel
rohr)(α) 9−15.38° (C= 1.0
14. CHc123)元素分析  Css Hto 
O2 理論値 分析値 IRνmax IH−NMR δ: 1.15 1.98 2.47 2.50 IH (%)    78.23  7.88(%)    
78.22  8.03(neat)  2120.3
280.3380cm−1(CD(J!3 ) (3H,d、  J=6.8H2) (11,brd、  J=5.9H2゜exchang
eable with  D20 )(IH,d、  
J=2.2H2) (IH,m) 4.02    (28,III) 4.22    (Ill、 dd、  J=2.2t
lz 、 5.9Hz >4.52     (2H,
S) 5.65〜5.82(28,III) 7.33    (5H,S) MS m/e :  230 (M” ) 、 91 
(100%)C+s H1e O2理論値230.13
07  (M” )分析値230.1338  (M”
 )〈化合物(15)の合成〉 上記得られた化合物(14) 1.450g (6,3
0m1110+)(7)酢Ml−)ル10mg溶液ニ酸
化白金(IV)44mQを懸濁させ、水素気流中空温で
4.5時間撹拌した。セライト濾過後、減圧下で溶媒を
留去し、粗生成物(化合物(15>>1.55旬を得た
bp 162℃ (0.3mmHg,
rohr) (α) 9-15.38° (C= 1.0
14. CHc123) Elemental analysis Css Hto
O2 theoretical value analysis value IRνmax IH-NMR δ: 1.15 1.98 2.47 2.50 IH (%) 78.23 7.88 (%)
78.22 8.03 (neat) 2120.3
280.3380cm-1 (CD(J!3) (3H, d, J=6.8H2) (11,brd, J=5.9H2゜exchange
easy with D20) (IH, d,
J=2.2H2) (IH, m) 4.02 (28, III) 4.22 (Ill, dd, J=2.2t
lz, 5.9Hz >4.52 (2H,
S) 5.65-5.82 (28, III) 7.33 (5H, S) MS m/e: 230 (M”), 91
(100%) C+s H1e O2 theoretical value 230.13
07 (M”) Analysis value 230.1338 (M”
) <Synthesis of compound (15)> Compound (14) obtained above 1.450 g (6,3
A solution of 44 mQ of platinum (IV) dioxide in 10 mg of vinegar Ml-) was suspended and stirred at temperature in a hydrogen stream for 4.5 hours. After filtration through Celite, the solvent was distilled off under reduced pressure to obtain a crude product (Compound (15>>1.55%).

上記粗生成物をシリカゲルカラムクロマトグラフィーで
精製した化合物(15)の分析結果は以下のとおりであ
った。
The analysis results of compound (15), which was obtained by purifying the above crude product by silica gel column chromatography, were as follows.

bp  157℃ (0,lmmHg、  にuge 
l rohr )〔α〕″g−7,72° (c= 1
.010. CHCf’3)元素分析  C15H24
02 IH 76,2210,24 75,8410,64 3340cnrl 理論値(%) 分析値(%) IR1,1lIlaX  (neat)11−1−NM
R(CDα3) δ:0.89    (3H,d。
bp 157℃ (0, lmmHg,
l rohr ) [α]″g-7,72° (c= 1
.. 010. CHCf'3) Elemental analysis C15H24
02 IH 76,2210,24 75,8410,64 3340cnrl Theoretical value (%) Analytical value (%) IR1,1lIlaX (neat)11-1-NM
R(CDα3) δ: 0.89 (3H, d.

0.95    (3H,t。0.95 (3H, t.

1.08〜2.80 (8H,III。1.08-2.80 (8H, III.

with 02 3.20〜3.58 (2H,m) 4.50    (2H,s) 7.32    (5H,s) MS  m/e  :  236 (M十 )。with 02 3.20-3.58 (2H, m) 4.50 (2H, s) 7.32 (5H,s) MS m/e: 236 (M 10).

J=6.6H2) J=7.8Hz > 1N、 exchangeable O) 91 (100%) 〈化合物(16)の合成〉 上記得られた粗生成物(化合物(15)>1.427(
Jのメタノール10rnl溶液にPd (OH) 27
1mgを懸濁させ、水素気流中室温で4.5時間撹拌し
た。セライト濾過後、減圧下で溶媒を留去し、得られた
残留物をシリカゲル25(lを用いたカラムクロマトグ
ラフィーに付し、エチルエーテル:ヘキサン=2:1(
容量)の流分から化合物(16)833mg(収率98
%(化合物(14)を1))を得た。
J=6.6H2) J=7.8Hz > 1N, exchangeable O) 91 (100%) <Synthesis of compound (16)> The crude product obtained above (compound (15)>1.427(
Pd(OH)27 in a 10rnl methanol solution of J
1 mg was suspended and stirred at room temperature in a hydrogen stream for 4.5 hours. After filtration through Celite, the solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography using 25 (l) of silica gel, ethyl ether:hexane = 2:1 (
Compound (16) 833 mg (yield 98
% (compound (14): 1)).

bp 105℃ (0,2mmf1g、  Kugel
rohr)〔α〕萱−7.93° (C= 1.008
. CH(1’3 )元素分析  C881802 CH 理論値(%)    65.71  12.41分析値
(%)    65.44  12.58IRymax
  (neat)  3340cm−1’H−NMR(
CDC13) δ:0.90     (3H,d、  J=6.6H
2)0.96     (3H,t、  J=8.1H
z )1.08〜1.84(7H,m) 1.76     (2N、  s、 exchang
eable withD20) 3.36    (IH,ddd、  J= 3.9t
!z。
bp 105℃ (0.2mmf1g, Kugel
rohr) [α] 萱-7.93° (C= 1.008
.. CH (1'3) elemental analysis C881802 CH Theoretical value (%) 65.71 12.41 Analysis value (%) 65.44 12.58IRymax
(neat) 3340cm-1'H-NMR (
CDC13) δ: 0.90 (3H, d, J=6.6H
2) 0.96 (3H, t, J=8.1H
z) 1.08~1.84 (7H, m) 1.76 (2N, s, exchange
easy withD20) 3.36 (IH, ddd, J= 3.9t
! z.

5、IH2、,8,4)12 ) 3.65     (2H,m’) MS m/e : 147 (M” +1> 、 70
 (100%)CeHsoO2理論値146.1307
分析値146.1311 〈化合物(17)の合成〉 上記得られた化合物(16) 740m(1(5,06
9mmol)の10rd!乳濁水に白金黒444mqを
懸濁させ、濃塩酸3滴を加え、酸素気流中55℃で13
時間撹拌した。これにエチルエーテルを加えた後、セラ
イト濾過し、濾液をざらにエチルエーテルで稀釈した後
、エーテル層を分取し無水硫酸マグネシウムで乾燥した
。減圧下で溶媒を留去し、得られた残留物850mgの
ベンゼン15mf!溶液をアルゴン気流中、Dean−
3tark装置を付して1.5時間加熱還流した。
5, IH2,,8,4)12) 3.65 (2H, m') MS m/e: 147 (M"+1>, 70
(100%) CeHsoO2 theoretical value 146.1307
Analysis value 146.1311 <Synthesis of compound (17)> Compound (16) obtained above 740 m (1 (5,06
9 mmol) 10th! Suspend 444 mq of platinum black in emulsion water, add 3 drops of concentrated hydrochloric acid, and stir at 55°C in an oxygen stream for 13 min.
Stir for hours. After adding ethyl ether to this, it was filtered through Celite, and the filtrate was roughly diluted with ethyl ether, and then the ether layer was separated and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was 850 mg of benzene 15 mf! The solution was heated under a stream of argon under Dean-
The mixture was heated under reflux for 1.5 hours using a 3tark apparatus.

反応液を飽和重曹水、飽和食塩水で順次洗浄した後無水
硫酸マグネシウムで乾燥した。減圧下で溶媒を画人後、
得られた残留物をシリカゲル25gを用いたカラムクロ
マトグラフィーに付し、エチルエーテル:ヘキサン=1
:4(容量)の流分から化合物(17)  558ma
 (収率78%)を得た。
The reaction solution was washed successively with saturated aqueous sodium bicarbonate and saturated brine, and then dried over anhydrous magnesium sulfate. After removing the solvent under reduced pressure,
The obtained residue was subjected to column chromatography using 25 g of silica gel, and ethyl ether:hexane=1
:Compound (17) from a stream of 4 (volume) 558ma
(yield 78%).

bp 126℃ (17mmHg、  Kugelro
hr)(α〕萱+49.32° (C= 1.034.
 CHCl3 )元素分析  C(lH+402 CH 理論値(%)    67.57  9.93分析値(
%)    67.28  10.09IR17max
  (neat)  t730cm−’’t−f−NM
R(CDC13) δ:0.99    (3H,d、  J=4.6H7
)1.03     (3H,t、  J=5.4H2
)1.20〜2.09 (5H,m> 2.20〜2.87(2H,m) 3.90    (IH,ddd、J=3.4Hz。
bp 126℃ (17mmHg, Kugelro
hr) (α) 萱+49.32° (C= 1.034.
CHCl3) Elemental analysis C(lH+402 CH Theoretical value (%) 67.57 9.93 Analysis value (
%) 67.28 10.09IR17max
(neat) t730cm-''t-f-NM
R (CDC13) δ: 0.99 (3H, d, J=4.6H7
)1.03 (3H, t, J=5.4H2
) 1.20-2.09 (5H, m> 2.20-2.87 (2H, m) 3.90 (IH, ddd, J=3.4Hz.

6.9l−1z 、 9.4Hz ) MS m/e : 143 (M” +t) 、 56
 (100%)CBH+402  理論値142.09
94  (M+ )分析値142.0991  (M+
 )このようにして得られた光学活性(48,5R)体
の上記化合物(17)と前記光学活性(4R,9R)体
の化合物(7)は、これらを原料として前記合成経路I
Vに従い、化合物(18)、化合物(19)を経由して
ミルベマイシンβ2の北半球部分である化合物(B)へ
と変換することができる。
6.9l-1z, 9.4Hz) MS m/e: 143 (M" +t), 56
(100%) CBH+402 Theoretical value 142.09
94 (M+) Analysis value 142.0991 (M+
) The thus obtained optically active (48,5R) compound (17) and the optically active (4R,9R) compound (7) are synthesized using the synthetic route I using these as raw materials.
According to V, it can be converted to compound (B), which is the northern hemisphere portion of milbemycin β2, via compound (18) and compound (19).

(発明の効果) 本発明の光学活性化合物は、天然に存在するミルベマイ
シンβ2を合成伍産化しうる中間体として重要である。
(Effects of the Invention) The optically active compound of the present invention is important as an intermediate capable of synthesizing naturally occurring milbemycin β2.

Claims (2)

【特許請求の範囲】[Claims] (1)下記式(A)で表わされる光学活性化合物。 ▲数式、化学式、表等があります▼(A) 上記式(A)において、Bnはベンジル基を表わし、*
の符号は不斉炭素原子を表わす。
(1) An optically active compound represented by the following formula (A). ▲There are mathematical formulas, chemical formulas, tables, etc.▼(A) In the above formula (A), Bn represents a benzyl group, *
The symbol represents an asymmetric carbon atom.
(2)請求項1記載の式(A)化合物が光学活性(R)
体である化合物。
(2) The compound of formula (A) according to claim 1 has optical activity (R)
A compound that is a body.
JP1072220A 1989-03-24 1989-03-24 Optically active compound Expired - Fee Related JPH0825940B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1072220A JPH0825940B2 (en) 1989-03-24 1989-03-24 Optically active compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1072220A JPH0825940B2 (en) 1989-03-24 1989-03-24 Optically active compound

Publications (2)

Publication Number Publication Date
JPH02250842A true JPH02250842A (en) 1990-10-08
JPH0825940B2 JPH0825940B2 (en) 1996-03-13

Family

ID=13482948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1072220A Expired - Fee Related JPH0825940B2 (en) 1989-03-24 1989-03-24 Optically active compound

Country Status (1)

Country Link
JP (1) JPH0825940B2 (en)

Also Published As

Publication number Publication date
JPH0825940B2 (en) 1996-03-13

Similar Documents

Publication Publication Date Title
JP2567430B2 (en) Carbinol derivative and method for producing the same
US4415501A (en) Alkenylzirconium reagents useful for prostaglandin analog synthesis
CA1164006A (en) Process for the preparation of prostanoids
JPH02250842A (en) Optically active compound
US5306846A (en) Synthesis of cyclitols from substituted arene diols
JP2596825B2 (en) Optically active compound
JPH02250843A (en) Optically active compound
JPS632972A (en) Novel prostaglandin e1 derivative and production thereof
JPS6263593A (en) Production of glycerol derivative
JP3266701B2 (en) Method for producing 2,3-dihydropolyprenol
JP4266408B2 (en) Method for producing optically active glycol
JP2737214B2 (en) Method for producing 4-hydroxy-2-cyclopentenone derivative
JP3446225B2 (en) Cyclopentane derivative and method for producing the same
JPH02250840A (en) Optically active alcohol
JP2836117B2 (en) Method for producing optically active tertiary allyl alcohol
JP3356462B2 (en) Method for producing optically active compound using novel oxazolidone derivative
JPS6253982A (en) 1-alkoxy-1,4a,5,6,7,7a-hexahydro-7-methylene-6-oxocyclopenta(c)pyran-4-carboxylic acid alkyl ester and production thereof
JPS63227536A (en) Hydroxyalkyne compound
JPS62155275A (en) Production of glycerol derivative
JPH0499740A (en) Production of 2-hydroxy-2,5,5,9-tetramethyldecalyl-ethanol
JPH0318630B2 (en)
Katana Progress Towards the Total Synthesis of Lancifodilactone G
JPH083177A (en) Method for producing en-yne compound using Lewis acid
JPH0331273A (en) Optically active furylcarbinols and production thereof
JPS6287539A (en) Production of 3,6,7-trisubstituted bicyclo-(3.3.0)-2-octene

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees